Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 20th November 2018
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study shows potential of avian influenza to infect humans
Avian influenza viruses isolated from Pakistan are able to escape vaccine immunity and adapt to infect humans.
Finding could lead to reduced vaccine efficiency

Avian influenza viruses isolated from Pakistan are able to escape vaccine immunity and adapt to infect humans, according to new research. This could lead to reduced vaccine efficiency and the possibility of human outbreaks.

The study led by The Pirbright Institute found that small changes to a surface protein of the H9N2 influenza A virus (haemagglutinin), enables the mutated virus to enter human cells.

In most cases, influenza viruses that infect humans and chickens use different host cell receptors in the early attachment stage.

“In this study, we demonstrated the mutant can bind to human-type cell receptors, but its preference for avian-like receptors remains,” explained Professor Munir Iqbal, head of the Avian Influenza group at Pirbright.

“H9N2 viruses cause moderate illness and death rates in domestic poultry and do not cause severe disease in humans, but the capability of an H9N2 avian influenza virus to bind to human-like receptors raises concern for potential human transmission.”

Researchers are now working to ascertain how this mutant H9N2 avian influenza A virus could generate a mutation that hits the right balance whilst retaining its ability to bind to human-like receptors.

This information will allow better screening of circulating avian influenza viruses for traits that may allow them to infect humans, providing early warning to their pandemic potential.

The study, Association of Increased Receptor-Binding Avidity of Influenza A(H9N2) Viruses with Escape from Antibody-Based Immunity and Enhanced Zoonotic Potential, is published in Emerging Infectious Diseases.  

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.